Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $2.676B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PRTA | PROTHENA CORP PLC | 11,284,280 | $580M | 21.7% | $10.98 | +184.0% | SHS | G72800108 |
| — | MORPHIC HLDG INC | 3,951,566 | $227M | 8.5% | $29.75 | — | COM | 61775R105 |
| ANAB | ANAPTYSBIO INC | 7,521,024 | $195M | 7.3% | $23.15 | +3.5% | COM | 032724106 |
| XNCR | XENCOR INC | 4,906,106 | $169M | 6.3% | $34.08 | +16.3% | COM | 98401F105 |
| RLAY | RELAY THERAPEUTICS INC | 4,487,776 | $164M | 6.1% | $37.18 | -11.4% | COM | 75943R102 |
| NUVB | NUVATION BIO INC | 13,711,517 | $128M | 4.8% | $11.19 | +1.9% | COM CL A | 67080N101 |
| STTK | SHATTUCK LABS INC | 3,318,410 | $96.2M | 3.6% | $31.39 | -6.9% | COM | 82024L103 |
| RCUS | ARCUS BIOSCIENCES INC | 3,335,247 | $91.59M | 3.4% | $26.10 | +9.4% | COM | 03969F109 |
| ALEC | ALECTOR INC | 4,242,634 | $88.37M | 3.3% | $18.72 | +0.7% | COM | 014442107 |
| SPRY | SILVERBACK THERAPEUTICS INC | 2,618,036 | $80.87M | 3.0% | $33.36 | -3.9% | COM | 82835W108 |
| KURA | KURA ONCOLOGY INC | 3,724,437 | $77.66M | 2.9% | $22.14 | +12.1% | COM | 50127T109 |
| — | MIRATI THERAPEUTICS INC | 464,298 | $75M | 2.8% | $97.40 | — | COM | 60468T105 |
| ORIC | ORIC PHARMACEUTICALS INC | 3,092,218 | $54.7M | 2.0% | $31.45 | -30.3% | COM | 68622P109 |
| NRIX | NURIX THERAPEUTICS INC | 1,967,950 | $52.21M | 2.0% | $29.56 | -0.7% | COM | 67080M103 |
| RNAM | AVIDITY BIOSCIENCES INC | 2,103,950 | $51.99M | 1.9% | $28.83 | -19.3% | COM | 05370A108 |
| JANX | JANUX THERAPEUTICS INC | 1,411,975 | $35.23M | 1.3% | $22.27 | 0.0% | COM | 47103J105 |
| — | SOLID BIOSCIENCES INC | 9,202,702 | $33.68M | 1.3% | $7.31 | — | COM | 83422E105 |
| — | GRITSTONE BIO INC | 3,421,287 | $31.24M | 1.2% | $3.94 | — | COM | 39868T105 |
| — | TRANSLATE BIO INC | 1,048,976 | $28.89M | 1.1% | $21.25 | — | COM | 89374L104 |
| — | ITEOS THERAPEUTICS INC | 1,035,864 | $26.57M | 1.0% | $25.40 | — | COM | 46565G104 |
| EWTX | EDGEWISE THERAPEUTICS INC | 1,224,175 | $26.11M | 1.0% | $32.43 | -15.7% | COM | 28036F105 |
| KYMR | KYMERA THERAPEUTICS INC | 519,416 | $25.19M | 0.9% | $40.93 | +6.1% | COM | 501575104 |
| DSGN | DESIGN THERAPEUTICS INC | 1,260,019 | $25.06M | 0.9% | $30.57 | -17.4% | COM | 25056L103 |
| — | AKOUOS INC | 1,975,984 | $24.8M | 0.9% | $22.50 | — | COM | 00973J101 |
| ARVN | ARVINAS INC | 321,724 | $24.77M | 0.9% | $76.50 | -9.3% | COM | 04335A105 |
| OVID | OVID THERAPEUTICS INC | 6,082,200 | $23.78M | 0.9% | $3.32 | +18.8% | COM | 690469101 |
| — | NEOLEUKIN THERAPEUTICS INC | 2,358,804 | $21.77M | 0.8% | $7.28 | — | COM | 64049K104 |
| ACIU | AC IMMUNE SA | 2,648,163 | $21M | 0.8% | $5.79 | +19.3% | SHS | H00263105 |
| — | ATRECA INC | 2,426,685 | $20.68M | 0.8% | $17.34 | — | CL A COM | 04965G109 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 754,545 | $16.76M | 0.6% | $22.21 | — | SPONSORED ADS | 152309100 |
| — | CHINOOK THERAPEUTICS INC | 931,650 | $13.15M | 0.5% | $15.86 | — | COM | 16961L106 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 200,000 | $10.64M | 0.4% | $53.56 | 0.0% | COM | 98943L107 |
| CRVS | CORVUS PHARMACEUTICALS INC | 3,579,377 | $9.557M | 0.4% | $2.75 | 0.0% | COM | 221015100 |
| — | KRONOS BIO INC | 387,357 | $9.277M | 0.3% | $29.87 | — | COM | 50107A104 |
| — | BCTG ACQUISITION CORP | 800,000 | $9.104M | 0.3% | $10.36 | — | COM | 05492W103 |
| — | NUVATION BIO INC | 963,333 | $8.969M | 0.3% | $10.45 | — | *W EXP 07/07/202 | 67080N119 |
| — | ALLOVIR INC | 447,012 | $8.824M | 0.3% | $27.50 | — | COM | 019818103 |
| CCCC | C4 THERAPEUTICS INC | 200,000 | $7.568M | 0.3% | $29.00 | +23.5% | COM STK | 12529R107 |
| — | CYCLERION THERAPEUTICS INC | 1,606,276 | $6.264M | 0.2% | $5.17 | — | COM | 23255M105 |
| — | VERVE THERAPEUTICS INC | 100,000 | $6.025M | 0.2% | $60.25 | — | COM | 92539P101 |
| — | SYROS PHARMACEUTICALS INC | 1,000,000 | $5.45M | 0.2% | $10.85 | — | COM | 87184Q107 |
| — | JIYA ACQUISITION CORP | 500,000 | $4.97M | 0.2% | $10.30 | — | COM CL A | 47760M102 |
| — | ALPINE IMMUNE SCIENCES INC | 522,635 | $4.704M | 0.2% | $8.79 | — | COM | 02083G100 |
| DYN | DYNE THERAPEUTICS INC | 215,000 | $4.524M | 0.2% | $21.96 | -14.4% | COM | 26818M108 |
| — | HEALTH SCIENCES ACQ CORP 2 | 400,000 | $4.08M | 0.2% | $11.00 | — | ORD SHS | G4411D109 |
| — | MAGENTA THERAPEUTICS INC | 366,867 | $3.588M | 0.1% | $11.84 | — | COM | 55910K108 |
| — | IGM BIOSCIENCES INC | 38,030 | $3.164M | 0.1% | $83.20 | — | COM | 449585108 |
| — | ODONATE THERAPEUTICS INC | 831,200 | $2.901M | 0.1% | $3.49 | — | COM | 676079106 |
| — | NGM BIOPHARMACEUTICALS INC | 143,567 | $2.831M | 0.1% | $30.29 | — | COM | 62921N105 |
| — | FORMA THERAPEUTICS HLDGS INC | 105,638 | $2.629M | 0.1% | $24.89 | — | SHS | 34633R104 |
| — | BOLT BIOTHERAPEUTICS INC | 150,000 | $2.319M | 0.1% | $32.91 | — | COM | 097702104 |
| BCAB | BIOATLA INC | 50,000 | $2.119M | 0.1% | $33.43 | +35.2% | COM | 09077B104 |
| — | BCLS ACQUISITION CORP | 200,000 | $2.106M | 0.1% | $11.14 | — | COM CL A | G0904B105 |
| MLTX | HELIX ACQUISITION CORP | 200,000 | $2.07M | 0.1% | $11.37 | — | COM CL A | G4444C102 |
| — | 5 01 ACQUISITION CORP | 200,000 | $1.994M | 0.1% | $10.17 | — | COM CL A | 33836P105 |
| — | CONSONANCE HFW ACQUISITION C | 200,000 | $1.987M | 0.1% | $9.94 | — | SHS CL A | G2445M103 |
| — | EUCRATES BIOMEDICAL ACQU COR | 200,000 | $1.969M | 0.1% | $9.98 | — | SHS | G3141W106 |
| — | FRAZIER LIFESCIENCES ACQU CO | 200,495 | $1.957M | 0.1% | $9.76 | — | CL A SHS | G3710A105 |
| PMVP | PMV PHARMACEUTICALS INC | 50,000 | $1.708M | 0.1% | $36.80 | -9.2% | COM | 69353Y103 |
| — | ARYA SCIENCES ACQU CORP IV | 150,000 | $1.608M | 0.1% | $10.47 | — | CL A | G31659108 |
| — | REPARE THERAPEUTICS INC | 50,000 | $1.559M | 0.1% | $31.02 | — | COM | 760273102 |
| — | FS DEVELOPMENT CORP II | 150,000 | $1.497M | 0.1% | $9.96 | — | COM CL A | 30318F100 |
| MGTX | MEIRAGTX HLDGS PLC | 94,819 | $1.47M | 0.1% | $16.89 | -15.4% | COM | G59665102 |
| — | CAREMAX INC | 100,000 | $1.29M | 0.0% | $12.90 | — | *W EXP 06/08/202 | 14171W111 |
| — | TURMERIC ACQUISITION CORP | 100,000 | $989K | 0.0% | $9.77 | — | CL A | G9127T108 |
| — | CONSONANCE HFW ACQUISITION C | 66,665 | $662K | 0.0% | $9.93 | — | *W EXP 10/28/202 | G2445M111 |
| — | EUCRATES BIOMEDICAL ACQU COR | 66,666 | $656K | 0.0% | $9.98 | — | *W EXP 10/23/202 | G3141W122 |
| — | FRAZIER LIFESCIENCES ACQU CO | 66,665 | $651K | 0.0% | $9.77 | — | *W EXP 11/30/202 | G3710A113 |
| — | KINNATE BIOPHARMA INC | 25,000 | $582K | 0.0% | $39.80 | — | COM | 49705R105 |
| — | OMEGA ALPHA SPAC | 50,000 | $498K | 0.0% | $9.90 | — | CL A | G6749V107 |
| — | F-STAR THERAPEUTICS INC | 46,000 | $395K | 0.0% | $10.83 | — | COM | 30315R107 |
| — | TURMERIC ACQUISITION CORP | 33,333 | $330K | 0.0% | $9.78 | — | *W EXP 10/08/202 | G9127T124 |